## Abstract ## BACKGROUND The current study was conducted to characterize the impact of a prior malignancy on the diagnosis, treatment, and outcome of highβgrade glioma. ## METHODS A retrospective study of 21 patients with a histologic diagnosis of glioblastoma multiforme (GBM), anaplastic astro
Cerebral diaschisis in patients with malignant glioma
β Scribed by Jack M. Rozental; Ross L. Levine; Robert J. Nickles; Jeffrey A. Dobkin; Joan M. Hanson
- Book ID
- 104652453
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 738 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
β¦ Synopsis
A positron emission tomography study using [18F]-fluorodeoxyglucose was undertaken to identify and quantitate whether diaschisis occurred in cerebral cortex, basal ganglia, or thalamus, as well as in cerebellar cortex and dentate nuclei in patients with malignant glioma. The relationship between diaschisis in these cerebral structures and clinically significant hemiparesis in patients was analysed. A 30% decrease in the regional metabolic rate for glucose in the cerebellar hemisphere contralateral to the tumor, and ipsilateral to the motor deficit, was identified and was statistically significant (p > 0.001). Decreased metabolism in the cerebellar hemisphere contralateral to the tumor was not seen in patients without hemiparesis. Parietal lobes affected by tumor had a larger decrease in metabolism than did frontal lobes with tumor (p > 0.01). The overall metabolism of the unaffected cerebellar hemisphere, relative to the peak metabolic activity of the brain, was not depressed in patients with tumor. In addition, the activity of subcortical nuclei was relatively unaffected by adjacent tumor or motor deficit.
π SIMILAR VOLUMES
Twenty-four patients with recurrent malignant glioma were treated with intravenous BCNU (80 mg/m2/ day x 3 days) alternating with AZQ (8 mg/mZ/day x 5 days) every 6--8 weeks. Twenty patients received two or more courses of chemotherapy, ten anaplastic astrocytomas (AA), eight glioblastomas (GBM), an